Skip to search formSkip to main contentSkip to account menu

mesalamine

Known as: Mesalazine, m Aminosalicylic Acid, 5 asa 
An agent derived from sulfasalazine, an antiinflammatory agent. Mesalamine may reduce inflammation through inhibition of cyclooxygenase and… 
National Institutes of Health

Related topics

Related topics

32 relations
24 HR mesalamine 375 MG Extended Release Oral Capsule [Apriso]Aminosalicylic AcidsDrug AllergyIn Blood

Narrower (11)

5-AminosalicylateAsacolAsacolitinAsacolon

Broader (2)

Anti-Inflammatory Agents, Non-Steroidalaminosalicylic acid

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial.
Highly Cited
2003
Highly Cited
2003
Medication nonadherence and the outcomes of patients with quiescent ulcerative colitis.
Highly Cited
2001
Highly Cited
2001
Prevalence of nonadherence with maintenance mesalamine in quiescent ulcerative colitis
OBJECTIVE:There are scant data regarding outpatient adherence in quiescent ulcerative colitis aside from patients enrolled in… 
Highly Cited
1999
Highly Cited
1999
Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial
Highly Cited
1999
Highly Cited
1999
Randomized clinical trial of Plantago ovata seeds (dietary fiber) as compared with mesalamine in maintaining remission in ulcerative colitis
Objective:Butyrate enemas may be effective in the treatment of active distal ulcerative colitis. Because colonic fermentation of… 
Highly Cited
1999
Highly Cited
1999
Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis
: Although 5‐aminosalicylic acid (5‐ASA) oral compounds are the standard maintenance treatment for ulcerative colitis in… 
Highly Cited
1997
Highly Cited
1997
Double‐blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis
Aminosalicylates are used as standard treatment for maintaining remission in ulcerative colitis. As yet, there is no other… 
Review
1995
Review
1995
Azathioprine and 6-Mercaptopurine in Crohn Disease
The antimetabolite agents azathioprine and 6-mercaptopurine are purine analogs that interfere with nucleic acid metabolism and… 
Highly Cited
1989
Highly Cited
1989
Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.
OBJECTIVE--To assess the safety and efficacy of a preparation of mesalazine (5-aminosalicylic acid) coated with a pH dependent… 
Highly Cited
1977
Highly Cited
1977
AN EXPERIMENT TO DETERMINE THE ACTIVE THERAPEUTIC MOIETY OF SULPHASALAZINE
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)